Page last updated: 2024-10-31

metoprolol and Fibrosis, Inflammatory Perianeurysmal

metoprolol has been researched along with Fibrosis, Inflammatory Perianeurysmal in 3 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (66.67)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Thompson, J	1
Julian, DG	1
Bullimore, DW	1
Ahmad, S	1

Other Studies

3 other studies available for metoprolol and Fibrosis, Inflammatory Perianeurysmal

Article	Year
Retroperitoneal fibrosis associated with metoprolol. British medical journal (Clinical research ed.), 1982, Jan-09, Volume: 284, Issue:6309 Topics: Humans; Male; Metoprolol; Middle Aged; Propanolamines; Retroperitoneal Fibrosis	1982
Retroperitoneal fibrosis associated with metoprolol. British medical journal (Clinical research ed.), 1982, Feb-27, Volume: 284, Issue:6316 Topics: Humans; Metoprolol; Propanolamines; Retroperitoneal Fibrosis; Time Factors	1982
Association of metoprolol and retroperitoneal fibrosis. American heart journal, 1996, Volume: 131, Issue:1 Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Constriction, Pathologic; Edema; Female	1996